Gene · 4176
Papers3,001
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,001
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Retasking of canonical antiviral factors into proviral effectors. | Curr Opin Virol | 2022 | 36242894 | PubTator, text mining | PubMed |
| Solving the MCM paradox by visualizing the scaffold of CMG helicase at active replisomes. | Nat Commun | 2022 | 36241664 | PubTator, text mining | PubMed |
| Identification of Candidate Genes in Breast Cancer Induced by Estrogen Plus Progestogens Using Bioinformatic Analysis. | Int J Mol Sci | 2022 | 36233194 | PubTator, text mining | PubMed |
| Safeguarding DNA Replication: A Golden Touch of MiDAS and Other Mechanisms. | Int J Mol Sci | 2022 | 36232633 | PubTator, text mining | PubMed |
| Construction of novel lncRNA-miRNA-mRNA ceRNA networks associated with prognosis of hepatitis C virus related hepatocellular carcinoma. | Heliyon | 2022 | 36217480 | PubTator, text mining | PubMed |
| Identifying the genes impacted by cell proliferation in proteomics and transcriptomics studies. | PLoS Comput Biol | 2022 | 36201535 | PubTator, text mining | PubMed |
| S6K1 phosphorylates Cdk1 and MSH6 to regulate DNA repair. | Elife | 2022 | 36189922 | PubTator, text mining | PubMed |
| Cuproptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of early-stage lung adenocarcinoma patients. | Front Genet | 2022 | 36186452 | PubTator, text mining | PubMed |
| Global circRNA expression changes predate clinical and histological improvements of psoriasis patients upon secukinumab treatment. | PLoS One | 2022 | 36174034 | PubTator, text mining | PubMed |
| ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold. | Theranostics | 2022 | 36168627 | PubTator, text mining | PubMed |
| Identification of the genetic central dogma in osteogenic differentiation of MSCs by osteoinductive medium from transcriptional data sets. | Chronic Dis Transl Med | 2022 | 36161200 | PubTator, text mining | PubMed |
| Proteomic analysis of arylamine N-acetyltransferase 1 knockout breast cancer cells: Implications in immune evasion and mitochondrial biogenesis. | Toxicol Rep | 2022 | 36158865 | PubTator, text mining | PubMed |
| High-Throughput Screening and Molecular Dynamics Simulation of Natural Products for the Identification of Anticancer Agents against MCM7 Protein. | Appl Bionics Biomech | 2022 | 36157125 | PubTator, text mining | PubMed |
| Modeling HPV-Associated Disease and Cancer Using the Cottontail Rabbit Papillomavirus. | Viruses | 2022 | 36146770 | PubTator, text mining | PubMed |
| Oxidative DNA Damage in the Pathophysiology of Spinal Cord Injury: Seems Obvious, but Where Is the Evidence? | Antioxidants (Basel) | 2022 | 36139802 | PubTator, text mining | PubMed |
| Targeting the Heterogeneous Genomic Landscape in Triple-Negative Breast Cancer through Inhibitors of the Transcriptional Machinery. | Cancers (Basel) | 2022 | 36139513 | PubTator, text mining | PubMed |
| Disulfiram Oxy-Derivatives Suppress Protein Retrotranslocation across the ER Membrane to the Cytosol and Initiate Paraptosis-like Cell Death. | Membranes (Basel) | 2022 | 36135864 | PubTator, text mining | PubMed |
| The Umbelopsis ramanniana Sensu Lato Consists of Five Cryptic Species. | J Fungi (Basel) | 2022 | 36135620 | PubTator, text mining | PubMed |
| Systematic analysis of MCM3 in pediatric medulloblastoma via multi-omics analysis. | Front Mol Biosci | 2022 | 36133906 | PubTator, text mining | PubMed |
| Single-cell analysis of the adaptive immune response to SARS-CoV-2 infection and vaccination. | Front Immunol | 2022 | 36119105 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4176/papers?page=18